Partners Innovation Fund (PIF) is an early-stage venture capital fund created in 2008 to promote the commercialization of technologies from Partners’ academic research institutions. PIF has $171 million in capital under management, including commitments from BWH and MGH, two of the principal teaching hospitals of the Harvard Medical School. We have also raised external capital from strategic and institutional investors. PIF invests exclusively in life science companies based on intellectual property created within our own research community. We enjoy privileged access to Partners’ intellectual property estate with the first look at newly disclosed inventions reflecting the inventive output from more than $1.8 billion of research expenditures annually.
The fund is managed by an experienced investment team that is co-located with the hospital licensing groups. We work side-by-side with principal investigators across the Partners network to identify and qualify opportunities. Initial investments are directed at the Seed and Series A stages, where our participation attracts capital and talent into the most difficult-to-fund phase of company development. We seek strong syndicate partners to help play an active role in accelerating innovation and supporting our portfolio companies through their entire financing lifecycles.
In addition to providing the necessary venture capital, we leverage our experience in starting and growing companies, our expertise in the life science industry, and our network of scientific and business talent to bring discoveries, inventions and innovations to the market benefit of patients worldwide.
To visit our website, click here.